111, Inc. (YI)
NASDAQ: YI · IEX Real-Time Price · USD
1.160
+0.150 (14.85%)
At close: Mar 28, 2024, 4:00 PM
1.159
-0.001 (-0.09%)
After-hours: Mar 28, 2024, 5:43 PM EDT
111, Inc. Market Cap
111, Inc. has a market cap or net worth of $84.83 million as of March 28, 2024. Its market cap has decreased by -62.86% in one year.
Market Cap
84.83M
Enterprise Value
36.32M
1-Year Change
-62.86%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since September 12, 2018, 111, Inc.'s market cap has decreased from $1.14B to $84.83M, a decrease of -92.58%. That is a compound annual growth rate of -37.46%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 85.80M | -2.83% |
Mar 26, 2024 | 88.30M | -4.64% |
Mar 25, 2024 | 92.60M | 2.89% |
Mar 22, 2024 | 90.00M | -13.13% |
Mar 21, 2024 | 103.60M | -19.94% |
Mar 20, 2024 | 129.40M | 2.70% |
Mar 19, 2024 | 126.00M | - |
Mar 18, 2024 | 126.00M | -1.95% |
Mar 15, 2024 | 128.50M | 1.98% |
Mar 14, 2024 | 126.00M | - |
Mar 13, 2024 | 126.00M | 4.91% |
Mar 12, 2024 | 120.10M | 2.91% |
Mar 11, 2024 | 116.70M | 1.57% |
Mar 8, 2024 | 114.90M | 0.70% |
Mar 7, 2024 | 114.10M | -2.89% |
Mar 6, 2024 | 117.50M | 2.17% |
Mar 5, 2024 | 115.00M | 0.79% |
Mar 4, 2024 | 114.10M | -2.23% |
Mar 1, 2024 | 116.70M | 0.78% |
Feb 29, 2024 | 115.80M | 0.70% |
Feb 28, 2024 | 115.00M | 0.79% |
Feb 27, 2024 | 114.10M | -3.63% |
Feb 26, 2024 | 118.40M | 3.77% |
Feb 23, 2024 | 114.10M | - |
Feb 22, 2024 | 114.10M | 1.51% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Corvus Pharmaceuticals | 88.76M |
Connect Biopharma Holdings | 88.67M |
Aclaris Therapeutics | 88.66M |
Chimerix | 88.32M |
BioXcel Therapeutics | 87.45M |
Rezolute | 84.01M |
Precision BioSciences | 83.69M |
Cue Biopharma | 83.03M |